Hubei Biocause Pharmaceutical Financial Flexibility Index

Latest as of September 2023: 0.00x

Hubei Biocause Pharmaceutical financial flexibility index. Hubei Biocause Pharmaceutical (000627) has a Financial Flexibility Index of 0.00x as of September 2023. Free cash flow of CN¥286.56 Million (operating CF CN¥276.06 Million minus capex CN¥10.51 Million) represents 0% of total liabilities (CN¥272.50 Billion). See Hubei Biocause Pharmaceutical free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.00x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥286.56 Million
Operating CF − Capex

Total Liabilities

CN¥272.50 Billion
CNY

Capital Expenditures

CN¥10.51 Million
CNY

Financial Flexibility Index of Hubei Biocause Pharmaceutical (2001–2023)

Financial flexibility index of Hubei Biocause Pharmaceutical from 2001 to 2023. Historical Financial Flexibility Index trend for Hubei Biocause Pharmaceutical across 18 annual periods. Check 000627 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Hubei Biocause Pharmaceutical Financial Flexibility Index by Year (2001–2023)

Hubei Biocause Pharmaceutical financial flexibility index by year from 2001 to 2023. Year-by-year free cash flow to debt coverage for Hubei Biocause Pharmaceutical. For the full cash flow conversion analysis, see 000627 cash flow metrics.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2023 0.04x CN¥9.60 Billion CN¥9.53 Billion CN¥268.30 Billion ▲ +18.7%
2022 0.03x CN¥7.66 Billion CN¥7.52 Billion CN¥254.00 Billion ▲ +53.1%
2021 0.02x CN¥4.46 Billion CN¥4.17 Billion CN¥226.43 Billion ▼ -81.4%
2020 0.11x CN¥21.74 Billion CN¥21.42 Billion CN¥204.81 Billion ▼ -38.1%
2019 0.17x CN¥29.32 Billion CN¥28.60 Billion CN¥170.92 Billion ▲ +71.2%
2018 0.10x CN¥15.26 Billion CN¥14.98 Billion CN¥152.24 Billion ▲ +841.3%
2017 0.01x CN¥1.21 Billion CN¥431.58 Million CN¥113.71 Billion ▼ -22.3%
2016 0.01x CN¥1.34 Billion CN¥-2.34 Billion CN¥97.48 Billion ▲ +243.7%
2015 -0.01x CN¥-5.97 Million CN¥-46.73 Million CN¥625.50 Million ▼ -102.5%
2013 0.38x CN¥274.33 Million CN¥130.53 Million CN¥720.71 Million ▼ -9.7%
2012 0.42x CN¥222.29 Million CN¥93.79 Million CN¥527.37 Million ▼ -8.5%
2011 0.46x CN¥216.32 Million CN¥66.95 Million CN¥469.47 Million ▼ -45.7%
2010 0.85x CN¥317.67 Million CN¥224.58 Million CN¥374.25 Million ▲ +112.3%
2007 0.40x CN¥183.32 Million CN¥118.56 Million CN¥458.52 Million ▼ -31.3%
2006 0.58x CN¥258.31 Million CN¥128.19 Million CN¥443.66 Million ▲ +183.8%
2005 0.21x CN¥73.17 Million CN¥48.66 Million CN¥356.70 Million ▼ -10.1%
2004 0.23x CN¥81.59 Million CN¥56.07 Million CN¥357.41 Million ▼ -25.0%
2001 0.30x CN¥68.77 Million CN¥37.30 Million CN¥226.09 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities